HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Merry L Tetef Selected Research

Granulocyte Colony-Stimulating Factor (G-CSF)

9/2004Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Merry L Tetef Research Topics

Disease

1Xeroderma Pigmentosum (Kaposi's Disease)
05/2009
1Breast Neoplasms (Breast Cancer)
05/2009
1Cardiotoxicity
09/2004
1Neoplasms (Cancer)
09/2004
1Sarcoma (Soft Tissue Sarcoma)
09/2004

Drug/Important Bio-Agent (IBA)

1Cisplatin (Platino)FDA LinkGeneric
05/2009
1Cytidine DeaminaseIBA
05/2009
1GemcitabineFDA Link
05/2009
1Levofloxacin (Levaquin)FDA Link
09/2004
1Dexrazoxane (Zinecard)FDA LinkGeneric
09/2004
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2004
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2004

Therapy/Procedure

1Therapeutics
05/2009
1Drug Therapy (Chemotherapy)
09/2004